We are live on
!
Find out more
SCM
SOL Capital Management Portfolio holdings
AUM
$206M
Turnover
90.91%
1-Year Est. Return
17.87%
This Fund
S&P 500
This Quarter
Est. Return
+5.18%
1 Year Est. Return
+17.87%
3 Year Est. Return
+56.62%
5 Year Est. Return
+56.1%
10 Year Est. Return
+238.92%
AUM
$354M
AUM Growth
-$9.29M
(-2.6%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-6.89%
Top 10 Holdings %
Top 10 Hldgs %
25.66%
Holding
255
New
9
Increased
72
Reduced
112
Closed
9
Avg Time Held
3.1
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.27M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$673K |
| 3 |
DuPont de Nemours
DD
|
+$416K |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$381K |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$307K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$12.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.42M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.31M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.15M |
| 5 |
iShares Short Maturity Bond ETF
NEAR
|
+$955K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.15% |
| 2 | Financials | 15% |
| 3 | Technology | 7.36% |
| 4 | Healthcare | 5.53% |
| 5 | Consumer Discretionary | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.5B
| $692K | 0.2% |
24,140
+725
| +3% | +$20.5K |
2016 Q4
3 quarters
|
|
127
Philip Morris
PM
$312B
| $688K | 0.19% |
6,194
-100
| -2% | -$11.6K |
2013 Q2
17 quarters
|
|
128
Nokia
NOK
$53.6B
| $678K | 0.19% |
113,312
+4,675
| +4% | +$29.1K |
2013 Q2
17 quarters
|
|
129
Yum China
YUMC
$15.1B
| $676K | 0.19% |
16,914
-200
| -1% | -$7.45K |
2016 Q4
3 quarters
|
|
130
iShares Russell 2000 Value ETF
IWN
$13.8B
| $673K | 0.19% |
5,425
+250
| +5% | +$29.5K |
2013 Q2
17 quarters
|
|
131
Direxion Daily Financial Bull 3x ETF
FAS
$2.11B
| $672K | 0.19% |
12,000
| – | – |
2013 Q3
16 quarters
|
|
132
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $655K | 0.18% |
21,925
| – | – |
2014 Q4
11 quarters
|
|
133
Vanguard Real Estate ETF
VNQ
$36.7B
| $650K | 0.18% |
7,822
+280
| +4% | +$23.4K |
2013 Q2
17 quarters
|
|
134
Qualcomm
QCOM
$191B
| $639K | 0.18% |
12,323
+2,020
| +20% | +$107K |
2013 Q2
17 quarters
|
|
135
Vanguard Health Care ETF
VHT
$19.9B
| $633K | 0.18% |
4,155
| – | – |
2016 Q3
4 quarters
|
|
136
Thermo Fisher Scientific
TMO
$258B
| $626K | 0.18% |
3,309
+124
| +4% | +$22.5K |
2013 Q2
17 quarters
|
|
137
iShares Core S&P Small-Cap ETF
IJR
$103B
| $616K | 0.17% |
8,293
+520
| +7% | +$36.4K |
2016 Q3
4 quarters
|
|
138
State Street SPDR S&P Bank ETF
KBE
$1.48B
| $612K | 0.17% |
13,562
-1,700
| -11% | -$72.9K |
2013 Q2
17 quarters
|
|
139
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $611K | 0.17% |
7,200
| – | – |
2013 Q2
17 quarters
|
|
140
Stellantis
STLA
$12.6B
| $610K | 0.17% |
34,050
+366
| +1% | +$5.06K |
2016 Q4
3 quarters
|
|
141
RTX Corp
RTX
$252B
| $604K | 0.17% |
8,271
+191
| +2% | +$14.1K |
2013 Q2
17 quarters
|
|
|
MON
142
DELISTED
Monsanto Co
MON
| $599K | 0.17% |
5,000
-100
| -2% | -$11.8K |
2013 Q2
17 quarters
|
|
143
McKesson
MCK
$116B
| $595K | 0.17% |
3,876
+320
| +9% | +$49.9K |
2013 Q2
17 quarters
|
|
144
Walmart Inc
WMT
$935B
| $574K | 0.16% |
22,032
-600
| -3% | -$15.7K |
2013 Q2
17 quarters
|
|
145
3M
MMM
$85.3B
| $573K | 0.16% |
3,264
-119
| -4% | -$20.6K |
2013 Q2
17 quarters
|
|
146
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
| $573K | 0.16% |
9,650
+450
| +5% | +$26.3K |
2016 Q3
4 quarters
|
|
147
PepsiCo
PEP
$175B
| $562K | 0.16% |
5,045
-50
| -1% | -$5.78K |
2013 Q2
17 quarters
|
|
148
Amgen
AMGN
$235B
| $561K | 0.16% |
3,010
-40
| -1% | -$7.09K |
2013 Q2
17 quarters
|
|
149
Lowe's Companies
LOW
$110B
| $556K | 0.16% |
6,950
-50
| -0.7% | -$3.83K |
2013 Q2
17 quarters
|
|
150
Banco Santander
SAN
$195B
| $546K | 0.15% |
82,098
-2,608
| -3% | -$16.6K |
2013 Q2
17 quarters
|
|
Similar funds
BOJHT
TC
CC
MFG
SPI
GL
TVM
LLWM
SOL Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, SOL Capital Management held 255 positions worth $354M, down 2.6% from $364M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
SOL Capital Management withdrew a net $24.4M in Q3 2017, closing 9 positions and reducing 112 holdings. Its most notable exit was Vanguard Short-Term Corporate Bond ETF, an estimated $1.31M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 56% a quarter earlier, followed by Financials and Technology.
Against the trend, SOL Capital Management opened a new position in DuPont de Nemours worth $437K.
- SOL Capital Management's largest Q3 2017 buy was DuPont de Nemours: 2,492 shares worth $437K.
- SOL Capital Management added most to Teva Pharmaceutical Industries Limited in Q3 2017, an estimated $1.27M increase.
- SOL Capital Management's biggest Q3 2017 reduction was Tapestry, cutting an estimated $12.5M.
- SOL Capital Management fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2017, selling an estimated $1.31M.
- SOL Capital Management's ten largest holdings make up 26% of its $354M portfolio in Q3 2017.
- SOL Capital Management opened 9 new positions and closed 9 in Q3 2017.
- SOL Capital Management's portfolio value fell 2.6% quarter-over-quarter to $354M.
Based on SOL Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.